Trials / Completed
CompletedNCT00058994
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-related Macular Degeneration
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that anecortave acetate is superior to placebo in maintenance of visual acuity at the 12- and 24-month visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | anecortave acetate |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2006-11-01
- Completion
- 2006-11-01
- First posted
- 2003-04-16
- Last updated
- 2012-11-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00058994. Inclusion in this directory is not an endorsement.